SOP Guide for Pharma

BA-BE Studies: SOP for Post-Dosing Restrictions and Observations – V 2.0

BA-BE Studies: SOP for Post-Dosing Restrictions and Observations – V 2.0

Standard Operating Procedure for Post-Dosing Restrictions and Observations in BA/BE Studies

Department BA-BE Studies
SOP No. SOP/BA-BE/093/2025
Supersedes SOP/BA-BE/093/2022
Page No. Page 1 of 10
Issue Date 17/04/2025
Effective Date 20/04/2025
Review Date 17/04/2026

1. Purpose

To establish a uniform procedure for enforcing post-dosing restrictions and conducting medical observations of volunteers during the clinical phase of BA/BE studies, ensuring subject safety and compliance with study protocol and regulatory expectations.

2. Scope

This SOP applies to all clinical research personnel involved in volunteer supervision, observation, and enforcement of behavioral or dietary restrictions after dosing in BA/BE studies.

3. Responsibilities

  • Clinical
Research Coordinator (CRC): Ensures all post-dosing procedures are implemented and documented as per protocol.
  • Study Nurse: Monitors vital signs and adverse events at scheduled intervals.
  • Principal Investigator (PI): Oversees clinical safety and reviews post-dose observation logs.
  • Volunteer Coordinator: Informs volunteers of restrictions and ensures compliance.
  • 4. Accountability

    The Study Director is accountable for ensuring that all post-dosing restrictions and monitoring procedures are followed as per study protocol, ICH-GCP, and Schedule Y requirements.

    5. Procedure

    5.1 Volunteer Instructions Post-Dosing

    1. Immediately after dosing, inform each volunteer about:
      • Dietary restrictions (no food for a defined period)
      • Water restriction (typically 1 hour post-dose unless protocol specifies otherwise)
      • No physical exertion or strenuous activity
      • Remaining in bed or sitting unless permitted
    2. Document instruction delivery in Annexure-1: Volunteer Post-Dose Restriction Log.

    5.2 Observation Timepoints and Parameters

    1. Monitor the following at defined intervals:
      • Vital signs (BP, pulse, respiration, temperature)
      • Level of consciousness
      • Presence of adverse events such as nausea, dizziness, or vomiting
    2. Record observations in Annexure-2: Post-Dosing Observation Sheet.

    5.3 Restriction Compliance Monitoring

    1. Assign staff to monitor subjects for:
      • Unauthorized food or fluid intake
      • Unauthorized movement or leaving the designated area
    2. Any non-compliance should be documented in Annexure-3: Deviation and Non-Compliance Log and reported to PI.

    5.4 Management of Symptoms and Adverse Events

    1. If any symptom is observed:
      • Inform the study physician immediately
      • Administer necessary treatment
      • Document in AE log and include in CRF

    5.5 Post-Restriction Reassessment

    1. After the restriction window (e.g., 4 hours), reassess vitals and general health status.
    2. Allow food and water only after clearance by study physician.
    3. Document time and type of first post-restriction meal and fluids.

    6. Abbreviations

    • BA: Bioavailability
    • BE: Bioequivalence
    • CRC: Clinical Research Coordinator
    • PI: Principal Investigator
    • CRF: Case Report Form
    • AE: Adverse Event

    7. Documents

    1. Volunteer Post-Dose Restriction Log – Annexure-1
    2. Post-Dosing Observation Sheet – Annexure-2
    3. Deviation and Non-Compliance Log – Annexure-3

    8. References

    • ICH E6(R2) – Good Clinical Practice
    • Indian GCP Guidelines
    • Study Protocol

    9. SOP Version

    Version: 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Volunteer Post-Dose Restriction Log

    Subject ID Date Time Restriction Informed Informed By Volunteer Signature
    VOL-093 17/04/2025 08:05 AM Sunita Reddy Rajesh Kumar

    Annexure-2: Post-Dosing Observation Sheet

    Time BP Pulse Temp Symptoms Observed Remarks
    09:00 AM 120/78 72 36.5°C None Stable

    Annexure-3: Deviation and Non-Compliance Log

    Date Subject ID Deviation Action Taken Reported To
    17/04/2025 VOL-093 Consumed water early Counselled PI & QA

    Revision History:

    Revision Date Revision No. Details Reason Approved By
    10/01/2022 1.0 Initial Release Protocol Requirement QA Head
    17/04/2025 2.0 Added Annexures and clarified observation intervals Audit Suggestion QA Head
    Exit mobile version